Literature DB >> 19684341

Assessment of seminal estradiol and testosterone levels as predictors of human spermatogenesis.

Qiufang Zhang1, Quan Bai, Yang Yuan, Ping Liu, Jie Qiao.   

Abstract

The proposed hypothesis for this study was that seminal testosterone/estradiol levels and/or their ratios may be a good indicator for predicting normal spermatogenesis. The concentrations of estradiol and testosterone in seminal fluid were measured using competitive immunoassay techniques in specimens collected from 192 infertile patients and 103 normospermic men. Infertile patients were subdivided into three groups according to their semen analysis results and testicular biopsy: oligozoospermia, obstructive azoospermia (OA), and nonobstructive azoospermia (NOA). Results showed that seminal testosterone levels in the infertile groups were lower than in the normospermic individuals (P < .01), whereas seminal estradiol levels in the OA group were significantly higher than those in normospermic and NOA groups (P < .01). Testosterone/estradiol ratios in the seminal plasma from the infertile groups were significantly lower than that in the normospermic group (P < .01). However, seminal estradiol levels among normospermic and NOA groups showed no significant differences. These results suggest that the local balance between androgen and estrogen, or their ratios, may play an important role in maintaining normal spermatogenesis. Also, decreased seminal testosterone/estradiol ratio may be a good indicator for identifying the absence of sperm production in NOA patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19684341     DOI: 10.2164/jandrol.109.007609

Source DB:  PubMed          Journal:  J Androl        ISSN: 0196-3635


  12 in total

1.  Multivariate analysis to predict letrozole efficacy in improving sperm count of non-obstructive azoospermic and cryptozoospermic patients: a pilot study.

Authors:  Giorgio Cavallini; Giulio Biagiotti; Elisa Bolzon
Journal:  Asian J Androl       Date:  2013-10-14       Impact factor: 3.285

2.  Expression of genomic functional estrogen receptor 1 in mouse sertoli cells.

Authors:  Jing Lin; Jia Zhu; Xian Li; Shengqiang Li; Zijian Lan; Jay Ko; Zhenmin Lei
Journal:  Reprod Sci       Date:  2014-03-10       Impact factor: 3.060

3.  Effects of electromagnetic fields exposure on plasma hormonal and inflammatory pathway biomarkers in male workers of a power plant.

Authors:  Zhaopin Wang; Ying Fei; Hui Liu; Shuangshuang Zheng; Zheyuan Ding; Wen Jin; Yifeng Pan; Zexin Chen; Lijuan Wang; Guangdi Chen; Zhengping Xu; Yongjian Zhu; Yunxian Yu
Journal:  Int Arch Occup Environ Health       Date:  2015-03-26       Impact factor: 3.015

Review 4.  Off label therapies for testosterone replacement.

Authors:  Lorenzo DiGiorgio; Hossein Sadeghi-Nejad
Journal:  Transl Androl Urol       Date:  2016-12

5.  Occurrence and reproductive roles of hormones in seminal plasma.

Authors:  Jana Vitku; Lucie Kolatorova; Richard Hampl
Journal:  Basic Clin Androl       Date:  2017-09-08

6.  Serum estradiol levels in infertile men with non-obstructive azoospermia.

Authors:  Nader Salama; Saeed Blgozah
Journal:  Ther Adv Reprod Health       Date:  2020-06-28

Review 7.  Endocrine aberrations of human nonobstructive azoospermia.

Authors:  Yong Tao
Journal:  Asian J Androl       Date:  2022 May-Jun       Impact factor: 3.054

Review 8.  Current medical management of endocrine-related male infertility.

Authors:  Joshua D Ring; Aye A Lwin; Tobias S Köhler
Journal:  Asian J Androl       Date:  2016 May-Jun       Impact factor: 3.285

9.  Seminal Plasma Anti-Müllerian Hormone: A Potential AI-Boar Fertility Biomarker?

Authors:  Isabel Barranco; Beatriz Fernandez-Fuertes; Lorena Padilla; Ariadna Delgado-Bermúdez; Asta Tvarijonaviciute; Marc Yeste
Journal:  Biology (Basel)       Date:  2020-04-10

Review 10.  The Vehicle Determines the Destination: The Significance of Seminal Plasma Factors for Male Fertility.

Authors:  Fengli Wang; Weina Yang; Sijin Ouyang; Shuiqiao Yuan
Journal:  Int J Mol Sci       Date:  2020-11-12       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.